Research Site

Iruma-Gun 350-0495

4 studies enrolling now · 10 studies all time

What they study most

Breast Cancer, Early Breast Cancer, Bullous Pemphigoid, COVID-19, Chronic Obstructive Pulmonary Disease (COPD), Dermatomyositis, Metastatic Non-small Cell Lung Cancer, Myasthenia Gravis, Myasthenia Gravis, Generalized, Myasthenia Gravis, Juvenile Form, Polymyositis, Dermatomyositis, Scleroderma, Systemic Sclerosis

Studies at this site

• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) — Recruiting now
• A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007) — Recruiting now
• A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis) — Recruiting now
• A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Recruiting now
• Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) — Running, not enrolling
• Ravulizumab Versus Placebo in Adult Participants With Dermatomyositis — Stopped early
• A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) — Completed
• A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid. — Stopped early
• Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger — Stopped early
• Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults — Completed